Oncotype DX Stories

Susie R.

The test indicated that she was in a group that was not likely to benefit from chemotherapy.

Susie’s Recurrence Score result was 16, indicating that her recurrence risk was in a low risk group.

Susie, a retired nurse, found a dimple in her breast during a self-exam in February 2007. Although a mammogram and an ultrasound showed no evidence of an abnormality, a surgeon with whom she had previously worked insisted that she come in for an exam. He was concerned with what he found.

A biopsy revealed that Susie, age 55, had breast cancer. The following week, she had a lumpectomy and a sentinel node biopsy. She had Stage I, node-negative cancer. Susie’s oncologist, surgeon and radiation oncologist agreed that she would need radiation therapy but could forgo chemotherapy. However, Susie, a former oncology nurse, was concerned that her cancer might be more likely to recur without chemotherapy.

“The Oncotype DX assay sealed the deal. Knowing I could make a game plan with some certainty helped me get back to normalcy.”

Her oncologist ordered the Oncotype DX assay. Susie’s Recurrence Score result was 16, indicating that her recurrence risk was in a low risk group. The test indicated that she was in a group that was not likely to benefit from chemotherapy, and her oncologist planned to treat Susie with radiation and tamoxifen.

“The Oncotype DX assay sealed the deal,” Susie said. “Knowing I could make a game plan with some certainty helped me get back to normalcy.”

Susie completed her radiation therapy in the summer of 2007 and continues to take tamoxifen. Now 56, Susie is busy helping raise two of her young grandchildren. She is also active in a garden club and enjoys skiing with her family.

Back to Search Results

Patient
Profile

Name: Susie R.
Age: 55
Year Diagnosed: 2007
Stage: I
Recurrence Score: 16

Submit
Your Story

Tell us about your experience with Oncotype DX